Skip to main content
Top
Published in: Calcified Tissue International 5/2024

Open Access 20-03-2024 | Opioids | Original Research

Pre-proenkephalin 1 is Downregulated Under Unloading and is Involved in Osteoblast Biology

Authors: Chiara Puri, Charlotte Dannenberg, Argia Ucci, Marco Ponzetti, Elisa Pucci, Luciana Silvestri, Patrick Lau, Petra Frings-Meuthen, Martina Heer, Nadia Rucci, Anna Teti, Antonio Maurizi

Published in: Calcified Tissue International | Issue 5/2024

Login to get access

Abstract

Pre-proenkephalin 1 (Penk1) is a pro-neuropeptide that belongs to the typical opioid peptide’s family, having analgesic properties. We previously found Penk1 to be the most downregulated gene in a whole gene profiling analysis performed in osteoblasts subjected to microgravity as a model of mechanical unloading. In this work, Penk1 downregulation was confirmed in the bones of two in vivo models of mechanical unloading: tail-suspended and botulinum toxin A (botox)-injected mice. Consistently, in the sera from healthy volunteers subjected to bed rest, we observed an inverse correlation between PENK1 and bed rest duration. These results prompted us to investigate a role for this factor in bone. Penk1 was highly expressed in mouse bone, but its global deletion failed to impact bone metabolism in vivo. Indeed, Penk1 knock out (Penk1−/−) mice did not show an overt bone phenotype compared to the WT littermates. Conversely, in vitro Penk1 gene expression progressively increased during osteoblast differentiation and its transient silencing in mature osteoblasts by siRNAs upregulated the transcription of the Sost1 gene encoding sclerostin, and decreased Wnt3a and Col1a1 mRNAs, suggesting an altered osteoblast activity due to an impairment of the Wnt pathway. In line with this, osteoblasts treated with the Penk1 encoded peptide, Met-enkephalin, showed an increase of Osx and Col1a1 mRNAs and enhanced nodule mineralization. Interestingly, primary osteoblasts isolated from Penk1−/− mice showed lower metabolic activity, ALP activity, and nodule mineralization, as well as a lower number of CFU-F compared to osteoblasts isolated from WT mice, suggesting that, unlike the transient inhibition, the chronic Penk1 deletion affects both osteoblast differentiation and activity. Taken together, these results highlight a role for Penk1 in the regulation of the response of the bone to mechanical unloading, potentially acting on osteoblast differentiation and activity in a cell-autonomous manner.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wang X, Xu J, Kang Q (2020) Neuromodulation of bone: role of different peptides and their interactions (review). Mol Med Rep 23(1):1–1 Wang X, Xu J, Kang Q (2020) Neuromodulation of bone: role of different peptides and their interactions (review). Mol Med Rep 23(1):1–1
2.
go back to reference Konttinen YT, Imai S, Suda A (1996) Neuropeptides and the puzzle of bone remodeling: state of the art. Acta Orthop Scand 67(6):632–639PubMed Konttinen YT, Imai S, Suda A (1996) Neuropeptides and the puzzle of bone remodeling: state of the art. Acta Orthop Scand 67(6):632–639PubMed
3.
go back to reference Comb M, Seeburg PH, Adelman J, Eiden L, Herbert E (1982) Primary structure of the human Met- and Leu-enkephalin precursor and its mRNA. Nature 295(5851):663–666PubMed Comb M, Seeburg PH, Adelman J, Eiden L, Herbert E (1982) Primary structure of the human Met- and Leu-enkephalin precursor and its mRNA. Nature 295(5851):663–666PubMed
4.
go back to reference Lutz P-E, Kieffer BL (2013) Opioid receptors: distinct roles in mood disorders. Trends Neurosci 36(3):195–206PubMed Lutz P-E, Kieffer BL (2013) Opioid receptors: distinct roles in mood disorders. Trends Neurosci 36(3):195–206PubMed
5.
go back to reference Fricker LD, Margolis EB, Gomes I, Devi LA (2020) Five decades of research on opioid peptides: current knowledge and unanswered questions. Mol Pharmacol 98(2):96–108PubMedPubMedCentral Fricker LD, Margolis EB, Gomes I, Devi LA (2020) Five decades of research on opioid peptides: current knowledge and unanswered questions. Mol Pharmacol 98(2):96–108PubMedPubMedCentral
6.
go back to reference Przewłocki R, Przewłocka B (2001) Opioids in chronic pain. Eur J Pharmacol 429(1–3):79–91PubMed Przewłocki R, Przewłocka B (2001) Opioids in chronic pain. Eur J Pharmacol 429(1–3):79–91PubMed
7.
go back to reference Barron BA (1999) Opioid peptides and the heart. Cardiovasc Res 43:13–16PubMed Barron BA (1999) Opioid peptides and the heart. Cardiovasc Res 43:13–16PubMed
8.
go back to reference Janković BD, Radulović J (1992) Enkephalins, brain and immunity: modulation of immune responses by methionine-enkephalin injected into the cerebral cavity. Int J Neurosci 67(1–4):241–270PubMed Janković BD, Radulović J (1992) Enkephalins, brain and immunity: modulation of immune responses by methionine-enkephalin injected into the cerebral cavity. Int J Neurosci 67(1–4):241–270PubMed
10.
go back to reference Keshet E, Polakiewicz RD, Itin A, Ornoy A, Rosen H (1989) Proenkephalin A is expressed in mesodermal lineages during organogenesis. Embo J 8(10):2917–2923PubMedPubMedCentral Keshet E, Polakiewicz RD, Itin A, Ornoy A, Rosen H (1989) Proenkephalin A is expressed in mesodermal lineages during organogenesis. Embo J 8(10):2917–2923PubMedPubMedCentral
11.
go back to reference Kew D, Kilpatrick DL (1990) Widespread organ expression of the rat proenkephalin gene during early postnatal development. Mol Endocrinol 4(2):337–340PubMed Kew D, Kilpatrick DL (1990) Widespread organ expression of the rat proenkephalin gene during early postnatal development. Mol Endocrinol 4(2):337–340PubMed
12.
go back to reference Barron BA, Oakford LX, Gaugl JF, Caffrey JL (1995) Methionine-enkephalin-Arg-Phe immunoreactivity in heart tissue. Peptides 16(7):1221–1227PubMed Barron BA, Oakford LX, Gaugl JF, Caffrey JL (1995) Methionine-enkephalin-Arg-Phe immunoreactivity in heart tissue. Peptides 16(7):1221–1227PubMed
13.
go back to reference Denning GM, Ackermann LW, Barna TJ, Armstrong JG, Stoll LL, Weintraub NL, Dickson EW (2008) Proenkephalin expression and enkephalin release are widely observed in non-neuronal tissues. Peptides 29(1):83–92PubMed Denning GM, Ackermann LW, Barna TJ, Armstrong JG, Stoll LL, Weintraub NL, Dickson EW (2008) Proenkephalin expression and enkephalin release are widely observed in non-neuronal tissues. Peptides 29(1):83–92PubMed
14.
go back to reference Capulli M, Rufo A, Teti A, Rucci N (2009) Global transcriptome analysis in mouse calvarial osteoblasts highlights sets of genes regulated by modeled microgravity and identifies a “mechanoresponsive osteoblast gene signature.” J Cell Biochem 107(2):240–252PubMed Capulli M, Rufo A, Teti A, Rucci N (2009) Global transcriptome analysis in mouse calvarial osteoblasts highlights sets of genes regulated by modeled microgravity and identifies a “mechanoresponsive osteoblast gene signature.” J Cell Biochem 107(2):240–252PubMed
15.
go back to reference Rosen H, Polakiewicz RD, Benzakine S, Bar-Shavit Z (1991) Proenkephalin A in bone-derived cells. Proc Natl Acad Sci USA 88(9):3705–3709PubMedPubMedCentral Rosen H, Polakiewicz RD, Benzakine S, Bar-Shavit Z (1991) Proenkephalin A in bone-derived cells. Proc Natl Acad Sci USA 88(9):3705–3709PubMedPubMedCentral
16.
go back to reference Elhassan AM, Lindgren JU, Hultenby K, Bergstrom J, Adem A (1998) Methionine-enkephalin in bone and joint tissues. J Bone Miner Res 13(1):88–95PubMed Elhassan AM, Lindgren JU, Hultenby K, Bergstrom J, Adem A (1998) Methionine-enkephalin in bone and joint tissues. J Bone Miner Res 13(1):88–95PubMed
17.
go back to reference Rosen H, Krichevsky A, Bar-Shavit Z (1998) The enkephalinergic osteoblast. J Bone Miner Res 13(10):1515–1520PubMed Rosen H, Krichevsky A, Bar-Shavit Z (1998) The enkephalinergic osteoblast. J Bone Miner Res 13(10):1515–1520PubMed
18.
go back to reference Rosen H, Krichevsky A, Polakiewicz RD, Benzakine S, Bar-Shavit Z (1995) Developmental regulation of proenkephalin gene expression in osteoblasts. Mol Endocrinol 9(11):1621–1631PubMed Rosen H, Krichevsky A, Polakiewicz RD, Benzakine S, Bar-Shavit Z (1995) Developmental regulation of proenkephalin gene expression in osteoblasts. Mol Endocrinol 9(11):1621–1631PubMed
19.
go back to reference Seitz S, Barvencik F, Gebauer M, Albers J, Schulze J, Streichert T, Amling M, Schinke T (2010) Preproenkephalin (Penk) is expressed in differentiated osteoblasts, and its deletion in Hyp mice partially rescues their bone mineralization defect. Calcif Tissue Int 86(4):282–293PubMed Seitz S, Barvencik F, Gebauer M, Albers J, Schulze J, Streichert T, Amling M, Schinke T (2010) Preproenkephalin (Penk) is expressed in differentiated osteoblasts, and its deletion in Hyp mice partially rescues their bone mineralization defect. Calcif Tissue Int 86(4):282–293PubMed
20.
go back to reference König M, Zimmer AM, Steiner H, Holmes PV, Crawley JN, Brownstein MJ, Zimmer A (1996) Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin. Nature 383(6600):535–538PubMed König M, Zimmer AM, Steiner H, Holmes PV, Crawley JN, Brownstein MJ, Zimmer A (1996) Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin. Nature 383(6600):535–538PubMed
21.
go back to reference Pérez-Castrillón JL, Olmos JM, Gómez JJ, Barrallo A, Riancho JA, Perera L, Valero C, Amado JA, González-Macías J (2000) Expression of opioid receptors in osteoblast-like MG-63 cells, and effects of different opioid agonists on alkaline phosphatase and osteocalcin secretion by these cells. Neuroendocrinology 72(3):187–194PubMed Pérez-Castrillón JL, Olmos JM, Gómez JJ, Barrallo A, Riancho JA, Perera L, Valero C, Amado JA, González-Macías J (2000) Expression of opioid receptors in osteoblast-like MG-63 cells, and effects of different opioid agonists on alkaline phosphatase and osteocalcin secretion by these cells. Neuroendocrinology 72(3):187–194PubMed
22.
go back to reference Sakata T, Sakai A, Tsurukami H, Okimoto N, Okazaki Y, Ikeda S, Norimura T, Nakamura T (1999) Trabecular bone turnover and bone marrow cell development in tail-suspended mice. J Bone Miner Res 14(9):1596–1604PubMed Sakata T, Sakai A, Tsurukami H, Okimoto N, Okazaki Y, Ikeda S, Norimura T, Nakamura T (1999) Trabecular bone turnover and bone marrow cell development in tail-suspended mice. J Bone Miner Res 14(9):1596–1604PubMed
23.
go back to reference Rucci N, Capulli M, Piperni SG, Cappariello A, Lau P, Frings-Meuthen P, Heer M, Teti A (2015) Lipocalin 2: a new mechanoresponding gene regulating bone homeostasis. J Bone Miner Res 30(2):357–368PubMed Rucci N, Capulli M, Piperni SG, Cappariello A, Lau P, Frings-Meuthen P, Heer M, Teti A (2015) Lipocalin 2: a new mechanoresponding gene regulating bone homeostasis. J Bone Miner Res 30(2):357–368PubMed
24.
go back to reference Warner SE, Sanford DA, Becker BA, Bain SD, Srinivasan S, Gross TS (2006) Botox induced muscle paralysis rapidly degrades bone. Bone 38(2):257–264PubMed Warner SE, Sanford DA, Becker BA, Bain SD, Srinivasan S, Gross TS (2006) Botox induced muscle paralysis rapidly degrades bone. Bone 38(2):257–264PubMed
25.
go back to reference Frings-Meuthen P, Buehlmeier J, Baecker N, Stehle P, Fimmers R, May F, Kluge G, Heer M (2011) High sodium chloride intake exacerbates immobilization-induced bone resorption and protein losses. J Appl Physiol 111(2):537–542PubMed Frings-Meuthen P, Buehlmeier J, Baecker N, Stehle P, Fimmers R, May F, Kluge G, Heer M (2011) High sodium chloride intake exacerbates immobilization-induced bone resorption and protein losses. J Appl Physiol 111(2):537–542PubMed
26.
go back to reference Capulli M, Ponzetti M, Maurizi A, Gemini-Piperni S, Berger T, Mak TW, Teti A, Rucci N (2018) A complex role for Lipocalin 2 in bone metabolism: global ablation in mice induces osteopenia caused by an altered energy metabolism. J Bone Miner Res 33(6):1141–1153PubMed Capulli M, Ponzetti M, Maurizi A, Gemini-Piperni S, Berger T, Mak TW, Teti A, Rucci N (2018) A complex role for Lipocalin 2 in bone metabolism: global ablation in mice induces osteopenia caused by an altered energy metabolism. J Bone Miner Res 33(6):1141–1153PubMed
27.
go back to reference Ponzetti M, Ucci A, Maurizi A, Giacchi L, Teti A, Rucci N (2022) Lipocalin 2 influences bone and muscle phenotype in the MDX mouse model of duchenne muscular dystrophy. Int J Mol Sci 23(2):958PubMedPubMedCentral Ponzetti M, Ucci A, Maurizi A, Giacchi L, Teti A, Rucci N (2022) Lipocalin 2 influences bone and muscle phenotype in the MDX mouse model of duchenne muscular dystrophy. Int J Mol Sci 23(2):958PubMedPubMedCentral
28.
go back to reference Lorensen WE, Cline HE (1987) Marching cubes: a high resolution 3D surface construction algorithm. ACM SIGGRAPH Comput Graph 21(4):163–169 Lorensen WE, Cline HE (1987) Marching cubes: a high resolution 3D surface construction algorithm. ACM SIGGRAPH Comput Graph 21(4):163–169
29.
go back to reference Feldkamp LA, Davis LC, Kress JW (1984) Practical cone-beam algorithm. J Opt Soc Am A 1(6):612–619 Feldkamp LA, Davis LC, Kress JW (1984) Practical cone-beam algorithm. J Opt Soc Am A 1(6):612–619
30.
go back to reference Pratt W (1991) Digital image processing, 2nd edn. Wiley, New York Pratt W (1991) Digital image processing, 2nd edn. Wiley, New York
31.
go back to reference Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Müller R (2010) Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res 25(7):1468–1486PubMed Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Müller R (2010) Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res 25(7):1468–1486PubMed
32.
go back to reference Rufo A, Del Fattore A, Capulli M, Carvello F, De Pasquale L, Ferrari S, Pierroz D, Morandi L, De Simone M, Rucci N, Bertini E, Bianchi ML, De Benedetti F, Teti A (2011) Mechanisms inducing low bone density in Duchenne muscular dystrophy in mice and humans. J Bone Miner Res 26(8):1891–1903PubMed Rufo A, Del Fattore A, Capulli M, Carvello F, De Pasquale L, Ferrari S, Pierroz D, Morandi L, De Simone M, Rucci N, Bertini E, Bianchi ML, De Benedetti F, Teti A (2011) Mechanisms inducing low bone density in Duchenne muscular dystrophy in mice and humans. J Bone Miner Res 26(8):1891–1903PubMed
33.
go back to reference Dempster DW, Compston JE, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR, Parfitt AM (2013) Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 28(1):2–17PubMed Dempster DW, Compston JE, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR, Parfitt AM (2013) Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 28(1):2–17PubMed
34.
go back to reference Sogi C, Takeshita N, Jiang W, Kim S, Maeda T, Yoshida M, Oyanagi T, Ito A, Kimura S, Seki D, Takano I, Sakai Y, Fujiwara I, Kure S, Takano-Yamamoto T (2020) Methionine enkephalin suppresses osteocyte apoptosis induced by compressive force through regulation of nuclear translocation of NFATc1. JBMR Plus 4(7):e10369PubMedPubMedCentral Sogi C, Takeshita N, Jiang W, Kim S, Maeda T, Yoshida M, Oyanagi T, Ito A, Kimura S, Seki D, Takano I, Sakai Y, Fujiwara I, Kure S, Takano-Yamamoto T (2020) Methionine enkephalin suppresses osteocyte apoptosis induced by compressive force through regulation of nuclear translocation of NFATc1. JBMR Plus 4(7):e10369PubMedPubMedCentral
35.
go back to reference Chen QC, Zhang Y (2022) The role of NPY in the regulation of bone metabolism. Front Endocrinol (Lausanne) 13:833485PubMed Chen QC, Zhang Y (2022) The role of NPY in the regulation of bone metabolism. Front Endocrinol (Lausanne) 13:833485PubMed
36.
go back to reference Janas A, Folwarczna J (2017) Opioid receptor agonists may favorably affect bone mechanical properties in rats with estrogen deficiency-induced osteoporosis. Naunyn Schmiedebergs Arch Pharmacol 390(2):175–185PubMed Janas A, Folwarczna J (2017) Opioid receptor agonists may favorably affect bone mechanical properties in rats with estrogen deficiency-induced osteoporosis. Naunyn Schmiedebergs Arch Pharmacol 390(2):175–185PubMed
37.
go back to reference Tanaka K, Kondo H, Hamamura K, Togari A (2019) Systemic administration of low-dose naltrexone increases bone mass due to blockade of opioid growth factor receptor signaling in mice osteoblasts. Life Sci 224:232–240PubMed Tanaka K, Kondo H, Hamamura K, Togari A (2019) Systemic administration of low-dose naltrexone increases bone mass due to blockade of opioid growth factor receptor signaling in mice osteoblasts. Life Sci 224:232–240PubMed
38.
go back to reference Thakur NA, DeBoyace SD, Margulies BS (2016) Antagonism of the Met5-enkephalin-opioid growth factor receptor-signaling axis promotes MSC to differentiate into osteoblasts. J Orthop Res 34(7):1195–1205PubMed Thakur NA, DeBoyace SD, Margulies BS (2016) Antagonism of the Met5-enkephalin-opioid growth factor receptor-signaling axis promotes MSC to differentiate into osteoblasts. J Orthop Res 34(7):1195–1205PubMed
39.
go back to reference Baldock PA, Driessler F, Lin S, Wong IP, Shi Y, Yulyaningsih E, Castillo L, Janmaat S, Enriquez RF, Zengin A, Kieffer BL, Schwarzer C, Eisman JA, Sainsbury A, Herzog H (2012) The endogenous opioid dynorphin is required for normal bone homeostasis in mice. Neuropeptides 46(6):383–394PubMed Baldock PA, Driessler F, Lin S, Wong IP, Shi Y, Yulyaningsih E, Castillo L, Janmaat S, Enriquez RF, Zengin A, Kieffer BL, Schwarzer C, Eisman JA, Sainsbury A, Herzog H (2012) The endogenous opioid dynorphin is required for normal bone homeostasis in mice. Neuropeptides 46(6):383–394PubMed
40.
go back to reference D’Ângelo Q, Queiroz-Junior CM, Maltos KLM, Ferreira AJ, Pacheco C, Soares RV (2020) The blockade of kappa opioid receptors exacerbates alveolar bone resorption in rats. Arch Oral Biol 120:104923PubMed D’Ângelo Q, Queiroz-Junior CM, Maltos KLM, Ferreira AJ, Pacheco C, Soares RV (2020) The blockade of kappa opioid receptors exacerbates alveolar bone resorption in rats. Arch Oral Biol 120:104923PubMed
41.
go back to reference Yue Q, Ma Y, Teng Y, Zhu Y, Liu H, Xu S, Liu J, Zhang X, Teng Z (2020) An updated analysis of opioids increasing the risk of fractures. PLoS ONE 15(4):e0220216PubMedPubMedCentral Yue Q, Ma Y, Teng Y, Zhu Y, Liu H, Xu S, Liu J, Zhang X, Teng Z (2020) An updated analysis of opioids increasing the risk of fractures. PLoS ONE 15(4):e0220216PubMedPubMedCentral
42.
go back to reference Coluzzi F, Pergolizzi J, Raffa RB, Mattia C (2015) The unsolved case of “bone-impairing analgesics”: the endocrine effects of opioids on bone metabolism. Ther Clin Risk Manag 11:515–523PubMedPubMedCentral Coluzzi F, Pergolizzi J, Raffa RB, Mattia C (2015) The unsolved case of “bone-impairing analgesics”: the endocrine effects of opioids on bone metabolism. Ther Clin Risk Manag 11:515–523PubMedPubMedCentral
44.
go back to reference Penchev R, Scheuring RA, Soto AT, Miletich DM, Kerstman E, Cohen SP (2021) Back pain in outer space. Anesthesiology 135(3):384–395PubMed Penchev R, Scheuring RA, Soto AT, Miletich DM, Kerstman E, Cohen SP (2021) Back pain in outer space. Anesthesiology 135(3):384–395PubMed
45.
go back to reference Maldonado R, Baños JE, Cabañero D (2018) Usefulness of knockout mice to clarify the role of the opioid system in chronic pain. Br J Pharmacol 175(14):2791–2808PubMedPubMedCentral Maldonado R, Baños JE, Cabañero D (2018) Usefulness of knockout mice to clarify the role of the opioid system in chronic pain. Br J Pharmacol 175(14):2791–2808PubMedPubMedCentral
46.
go back to reference Rosen H, Bar-Shavit Z (1994) Dual role of osteoblastic proenkephalin derived peptides in skeletal tissues. J Cell Biochem 55(3):334–339PubMed Rosen H, Bar-Shavit Z (1994) Dual role of osteoblastic proenkephalin derived peptides in skeletal tissues. J Cell Biochem 55(3):334–339PubMed
47.
go back to reference Winkler DG (2003) Osteocyte control of bone formation via sclerostin, a novel BMP antagonist. EMBO J 22(23):6267–6276PubMedPubMedCentral Winkler DG (2003) Osteocyte control of bone formation via sclerostin, a novel BMP antagonist. EMBO J 22(23):6267–6276PubMedPubMedCentral
48.
go back to reference Zhang R, Oyajobi BO, Harris SE, Chen D, Tsao C, Deng H-W, Zhao M (2013) Wnt/β-catenin signaling activates bone morphogenetic protein 2 expression in osteoblasts. Bone 52(1):145–156PubMed Zhang R, Oyajobi BO, Harris SE, Chen D, Tsao C, Deng H-W, Zhao M (2013) Wnt/β-catenin signaling activates bone morphogenetic protein 2 expression in osteoblasts. Bone 52(1):145–156PubMed
49.
go back to reference Nakashima A, Katagiri T, Tamura M (2005) Cross-talk between Wnt and bone morphogenetic protein 2 (BMP-2) signaling in differentiation pathway of C2C12 myoblasts. J Biol Chem 280(45):37660–37668PubMed Nakashima A, Katagiri T, Tamura M (2005) Cross-talk between Wnt and bone morphogenetic protein 2 (BMP-2) signaling in differentiation pathway of C2C12 myoblasts. J Biol Chem 280(45):37660–37668PubMed
Metadata
Title
Pre-proenkephalin 1 is Downregulated Under Unloading and is Involved in Osteoblast Biology
Authors
Chiara Puri
Charlotte Dannenberg
Argia Ucci
Marco Ponzetti
Elisa Pucci
Luciana Silvestri
Patrick Lau
Petra Frings-Meuthen
Martina Heer
Nadia Rucci
Anna Teti
Antonio Maurizi
Publication date
20-03-2024
Publisher
Springer US
Keywords
Opioids
Opioids
Published in
Calcified Tissue International / Issue 5/2024
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-024-01199-z

Other articles of this Issue 5/2024

Calcified Tissue International 5/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.